What Are the Most Ethically Salient Implications of Epigenetic Age Testing?
AMA Journal of Ethics · 01.12.2025 · 27 (12) · E828-833
DOI: 10.1001/amajethics.2025.828 ↗Kurz gefasst
Fachartikel in der Zeitschrift AMA Journal of Ethics, online erschienen am 01.12.2025. Verfasst von Michael Hauskeller und 1 weiteren Autor:innen. Beteiligte Einrichtung: Professor of philosophy at the University of Liverpool in the United Kingdom. Hauptthemen laut MEDLINE: Genetic Testing, Epigenesis, Genetic, Aging, Epigenomics. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
This commentary on a case considers how clinicians should help patients interpret results of tests that might be personally meaningful but not clinically actionable. Tests of biological age, for example, can easily lead to patient misunderstandings that can increase risks of psychological harm and make age-related discrimination seem justifiable. This commentary suggests that companies offering epigenetic testing should be more transparent about these tests' reliability and limitations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Professor of philosophy at the University of Liverpool in the United Kingdom.
- Doctoral researcher in the Department of Philosophy at the University of Liverpool in the United Kingdom.
Zitieren
APA
Hauskeller, M., & Shore, L. (2025). What Are the Most Ethically Salient Implications of Epigenetic Age Testing?. AMA Journal of Ethics, 27(12), E828-833. https://doi.org/10.1001/amajethics.2025.828
Vancouver
Hauskeller M, Shore L. What Are the Most Ethically Salient Implications of Epigenetic Age Testing?. AMA Journal of Ethics. 2025;27(12):E828-833. doi:10.1001/amajethics.2025.828
BibTeX
@article{Hauskeller2025,
author = {Hauskeller, Michael and Shore, Liam},
title = {What Are the Most Ethically Salient Implications of Epigenetic Age Testing?},
journal = {AMA Journal of Ethics},
year = {2025},
volume = {27},
number = {12},
pages = {E828--833},
doi = {10.1001/amajethics.2025.828}
}
EUVIMED